Southport Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Southport Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,000	Closed	-$202K	–	38
2017 Q2	$202K	Hold	10,000	–	–	0.54%	24
2017 Q1	$269K	Sell	10,000 -15,000	-60%	-$306K	0.58%	23
2016 Q4	$476K	Hold	25,000	–	–	0.64%	40
2016 Q3	$489K	Sell	25,000 -25,000	-50%	-$423K	0.95%	26
2016 Q2	$748K	Hold	50,000	–	–	1.5%	26
2016 Q1	$460K	Buy	+50,000	New	+$606K	0.76%	27

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Southport Management's FLXN Position: Q3 2017 in Review

Southport Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2017, closing a stake of 10,000 shares — an estimated $202K sold.

Southport Management first reported a position in FLXN in Q1 2016 and held it in 6 quarters. The position peaked at $748K in Q2 2016. 116 funds tracked by Wall St. Rank hold FLXN as of Q3 2017.

Southport Management reported no remaining Flexion Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
Southport Management sold 10,000 Flexion Therapeutics, Inc. shares in Q3 2017, an estimated $202K.
Southport Management first reported a position in Flexion Therapeutics, Inc. in Q1 2016 and held it in 6 quarters.
Southport Management's Flexion Therapeutics, Inc. position peaked at $748K in Q2 2016.
116 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2017.

Based on Southport Management's 13F filing for Q3 2017, filed 14 Nov 2017.